Until recently, steroid hormones were believed to act only on cells containing intracellular receptors. However, recent evidence suggests that steroids have specific and rapid effects at the cellular membrane.
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Using whole-cell patch-clamp techniques, 17P-estradiol was found to reduce Ba2+ entry reversibly via Ca"+ channels in acutely dissociated and cultured neostriatal neurons. The effects were sex-specific, i.e., the reduction of Ba"+ currents was greater in neurons taken from female rats. 17p-Estradiol primarily targeted L-type currents, and their inhibition was detected reliably within seconds of administration.
The maximum reduction by 17P-estradiol occurred at picomolar concentrations.
17P-Estradiol conjugated to bovine serum albumin also reduced Ba"+ currents, suggesting that the effect occurs at the membrane surface. Dialysis with GTPyS prevented reversal of the modulation, suggesting that 17P-estradiol acts via G-protein activation. 17a-Estradiol also reduced Ba2+ currents but was significantly less effective than 17p-estradiol.
Estriol and 4-hydroxyestradiol were found to reduce Ba2+ currents with similar efficacy to 17p-estradiol, whereas estrone and 2-methoxyestriol were less effective. Tamoxifen also reduced Ba2+ currents but did not occlude the effect of 17P-estradiol.
These results suggest that at physiological concentrations, 17P-estradiol can have immediate actions on neostriatal neurons via nongenomic signaling pathways. Key words: estradiol; neostriatum; patch clamp; Ca" current; estrogen receptor; neuromodulation; steroid; nongenomic Estradiol, as well as other steroid hormones, is known to alter gene transcription via intracellular receptors (Pfaff, 1980; Pfaff and Schwartz-Giblin, 1988; Carson-Jurica et al., 1990) . As expected, estrogen receptors are found in regions often associated with reproduction, such as the mammalian hypothalamus and uterus (Stance1 et al., 1973; Stumpf and Sar, 1978; McEwen, 1979) . However, steroid hormones also act in regions that do not contain intracellular steroid receptors. These effects often are too fast to be attributed to genomic activation and are believed to occur via stimulation of membrane receptors.
One region in which a membrane receptor may be important is the brain, where estradiol has rapid effects that are not readily attributable to traditional steroid receptors. For example, estradiol decreases the spontaneous firing of medial preoptic area neurons (Kelly et al., 1977) and increases the firing rate of pituitary cells (Dufy et al., 1979) . Estradiol also potentiates EPSPs in the hippocampus (Wong and Moss, 1991,1992) and Glu responses in the cerebellum (Smith et al., 1987 (Smith et al., , 1989 ) while hyperpolarizing medial amygdala neurons (Nabekura et al., 1986; Minami et al., 1990) . In the guinea pig, estrogen suppresses p-opioidand GABA,-based hyperpolarization of hypothalamic arcuate neurons (Kelly et al., 1992) . Moreover, estrogen directly potentiates K+-stimulated dopamine release in rat nucleus accumbens (Thompson and Moss, 1994) . Another target of estrogen that lacks intracellular estrogen receptors is the adult neostriatum (Pfaff and Keiner, 1973; Stumpf and Sar, 1978; Simerly et al., 1990) . Administration of estradiol in vivo potentiates the induced release of dopamine and rotational behavior (Becker, 1990a,b; Castner et al., 1993) . Pulsatile administration of estradiol in vitro rapidly stimulates neostriatal dopamine release (Becker et al., 1990a) . Estrogen pretreatment increases the firing rate of neostriatal neurons in response to dopamine (Arnauld et al., 1981) , possibly via changes in D,/D, dopamine-receptor coupling (Demotes-Mainard et al., 1990) or dopamine-receptor binding (Gordon and Perry, 1983; Clopton and Gordon, 1986; Levesque and Di Paolo, 1988; Tonnaer et al., 1989; Bazzett and Becker, 1994) . Moreover, estrogen implanted directly into the neostriatum enhances sensorimotor performance (Becker et al., 1987) . Many of these effects of estradiol on the neostriatum are rapid, with the earliest measured changes occurring within 15 min of steroid administration (Levesque and Di Paolo, 1988) .
Although the actions of estradiol on neostriatal functioning are widespread, the mechanism by which estradiol acts is unclear. Intracellular estrogen receptors have been reported in the neostriatum of newborn rat pups (Toran-Allerand et al., 1992 ), but they have not been reported in the adult. Moreover, the effects of estradiol within the neostriatum are too fast to be attributed to genome activation. The most parsimonious hypothesis is that estradiol affects the neostriatum via a membrane receptor. To test this, estradiol was applied to isolated neostriatal neurons while measuring voltage-gated Bazt currents. Bazt currents through Cazt channels were chosen as an assay because of shown to be regulated by estrogen. The experiments reported in this study show that at physiologically relevant concentrations, 17/3-estradiol acts in a steroid-specific manner to activate a G-protein-coupled membrane receptor that reduces L-type currents in rat neostriatal neurons. Furthermore, the effects were sex-specific, being larger in neurons taken from females than males.
MATERIALS AND METHODS
Acute-dissociation procedure.
In most experiments, neostriatal neurons from prepubertal Sprague-Dawley female rats (4 weeks) were acutely dissociated using methods similar to those described previously (Surmeier et al., 1991 (Surmeier et al., , 1992 with fetal calf serum (lo%, HyClone, Logan, UT), insulin (5 mgiml), penicillin (50 U/ml), and streptomycin (50 mgiml; latter three from Sigma). The striata were triturated using a graded series of fire-polished Pasteur pipettes and then filtered to remove debris. Viability was determined with a trypan blue exclusion test. The cells were plated into Lux dishes at a density of 1-2 X lo6 cells/dish.
Cultures then were incubated in a 95% humidity/5% CO, atmosphere and fed twice/week with a basal media supplemented with 5% fetal calf serum and 5% horse serum (HyClone) until recording (-1 week after plating). Before recording, the culture dishes were washed for 20 min with steroid-free bath solution. The same recording (Fig. U) . The reduction by 17/3-estradiol on Ba2+ currents was observed in both acutely dissociated and primary cultured neostriatal neurons, suggesting that the enzymatic treatment of the acutely isolated cells was not responsible for the actions of the hormone (Fig. 2B) . The magnitude of the Bazt current reduction by 17P-estradiol was similar in size to that observed when neostriatal dopamine or acetylcholine receptors are stimulated (Howe and Surmeier, 1995; Surmeier et al., 1995) and was in the range of effects observed when other neuromodulators are applied to neurons excised from central nervous system tissue.
presence of 17P-estradiol).
The measurements from this cell and from five others are plotted as a function of time in Figure  3B . This plot shows that although the 17P-estradiol tended to diminish with time, the resistant current did not, suggesting that rundown of the 17P-estradiol-sensitive current, rather than desensitization, was responsible for the change. We cannot exclude completely, however, the possibility that desensitization occurred in parallel with rundown.
Of the currents expressed by neostriatal neurons, L-type currents are particularly susceptible to rundown, suggesting that these currents are targeted by the 17P-estradiol modulation.
17j.&Estradiol modulates L-type Ca*+ channels
The effects of 17P-estradiol were sex-dependent. Although neostriatal neurons taken from both male and female rats were affected by 17/3-estradiol, the modulation was significantly greater (p < 0.0001) in tissue taken from female rats (15.11 ? 1.9%, n = 20 from 4 females vs 7.28 i OX%, II = 29, 8 males; Fig. 2C ). The current sensitive to 17P-estradiol activated rapidly (-3 msec) and displayed little to no inactivation with Ba2+ as the charge carrier (Fig. 2D,E) .
To characterize better the currents affected by estradiol, membrane-permeability estimates were generated using the Goldman-Hodgkin-Katz constant-current equation (Hille, 1994) . The permeability estimates of the 17P-estradiol-sensitive current then were fit with a Boltzmann function (Fig. 4AJ) . The steady-state voltage dependence of the estradiol-sensitive current was consistent with it being composed of N-, P-, or L-type currents (Bargas et al., 1994) . To determine which of these currents was being modulated, occlusion experiments with channel-specific antagonists were performed. The P-type-and N-type-channel toxins w-AgTx-IVA (100 nM) and w-CTx-GVIA (1 FM) only partially occluded the effects of 17P-estradiol (Fig. 5A,C) . Experiments using the mixed N-and Q-type Ca'+-channel toxin o-CTx-MVIIC (1 PM) yielded similar results (n = 4; data not shown). However, nifedipine (5 PM), an L-type-channel antagonist, produced a much stronger occlusion of the response to 17/3-estradiol, suggesting that 17/3-estradiol targeted primarily L-type currents (Fig.   5B,C) .
Often, the reduction in peak current by 17P-estradiol diminished with repeated application.
There are two potential explanations for this result: desensitization of the estrogen-signaling pathway, or nonspecific rundown of estrogen-sensitive currents. To help determine which mechanism was responsible, 17P-estradiol was applied at periodic intervals and the modulation was monitored. Figure 3A is a plot of peak current as a function of time in a neuron in which the modulation by estradiol diminished with repeated application. Two measurements were taken from this time course: the amplitude of the estradiol modulation and the amplitude of the "resistant" current (i.e., that portion of the current left in the The actions of estradiol are steroid-specific The effects of 17P-estradiol were dose-dependent, with a maximal reduction of Bazt currents occurring at 100 pM (concentrations of 10 nM and 1 PM did not reduce the current further). 17a-Estradiol, the stereoisomer of the endogenous 17/3-estradiol (considered to be physiologically inactive at the intracellular estrogen receptor), also was found to reduce Ba2+ currents. However, the reduction by 17cu-estradiol was significantly less (p < 0.002) than that of 17/3-estradiol (Fig. 6A) considered to be an antagonist at the intracellular estrogen receptor, was found to reduce Ba2+ currents as well (11.7 i 1.3% reduction of maximal current; IZ = 17), although significantly less (p < 0.005) than 17P-estradiol. Moreover, tamoxifen only slightly occluded the inhibition of 17P-estradiol on Ba2+ currents (18.0 -C 8.2%; IZ = 10).
Shown in

17/S-Estradiol acts at a surface receptor
17P-Estradiol appears to reduce Ba2+ currents by acting at the membrane surface, not on an intracellular receptor. E-BSA, which cannot penetrate the cellular membrane, also was found to inhibit Bazt currents (Fig. 7A,B) . In this E-BSA, estradiol was conjugated on the 17th carbon. Because the inhibition of 17oc-estradiol on Bazf currents was significantly less than that of 17/3-estradiol ( Fig. 6A) , it was unclear whether the efficacy of E-BSA was caused, at least in part, by the presence of free estradiol. To verify that 17/3-estradiol acts at the membrane surface, a subset of cells was intracellularly perfused with 17P-estradiol.
17P-Estradiol was allowed to diffuse into the cell for at least 5 min before we applied 17/3-estradiol externally (time between membrane rupture and recording). Based on estimates of dialysis times for similar compounds with cells similar in size to ours (Pusch and Neher, 1988) , the concentration of estradiol in the cell interior and the electrode should have equilibrated in this period. After dialysis, 17/3-estradiol (1 PM) applied extracellularly still inhibited Bazt currents (Fig. 7C) .
The inhibition of Ba2+ currents by 17/3-estradiol appeared to depend on activation of a G-protein. Under normal conditions, the 17P-estradiol modulation readily reversed when the hormone was removed (70.4 -C 10.0% of the current blocked by 17p-estradiol reversed after return to the control solution; IZ = 7, Fig.  8B ). However, when the cell was dialyzed with GTPyS (400 FM) recovery after 17fl-estradiol removal was significantly (p < 0.05) reduced (40.5 t 10.9%, n = 8; Fig. 8&I ). This pattern suggests that 17/?-estradiol activates a G-protein in a signaling pathway targeting Ca2+ channels.
G-proteins are capable of modulating Ca2+ channels either via cytosolic second-messenger pathways or via direct interaction with the channel or an associated protein (Hille, 1992a) . This latter signaling pathway often is referred to as membranedelimited.
A common characteristic of membrane-delimited inhibition of Ba*+ currents is the ability of strong membrane depolarization to reverse the modulation temporarily.
To test whether the pathway mediated by the effects of 17P-estradiol shared this property, agonist was applied with and without a brief (30 msec) depolarizing (100 mV) prepulse. The modulation of Ba2+ currents by 17P-estradiol was unaffected by the strong prepulse [the modulation after a prepulse was 100.6 ? 4.6% (n = 22) of the control; Fig. 9A-C Figure 7 . The effects of 17P-estradiol occur at the cellular membrane.A, E-BSA (52 PM) also was found to inhibit neostriatal Ba'+ currents, suggesting that the immediate actions of 17/3-estradiol occur at the membrane surface. The administration of 17P-estradiol (52 PM) and E-BSA produced a similar reduction in current. B, Individual traces taken from the time course shown in A. C, Dialyzing the inside of the cell with 17P-estradiol (100 PM) did not influence the response to 17P-estradiol (1 PM) administered externally, suggesting an effect at the extracellular face of the membrane. Inset, Statistical summary of the percent reduction of the whole-cell Ba2+ current inhibited by 1 PM 17P-estradiol after intracellular dialysis. This finding suggests that 17P-estradiol does not require an elevation of intracellular Ca2+ to inhibit voltageactivated currents (Fig. 70) .
DISCUSSION
These results demonstrate that physiological concentrations of 17P-estradiol rapidly reduce L-type currents in neostriatal neurons. This modulation was sex-specific in that 17P-estradiol was more effective in neurons acquired from female rats than those from males. The effect was also steroid-specific:
17cu-estradiol, estrone, and 2-methoxyestriol were less effective in modulating Ba2+ currents than 17P-estradiol. Finally, these effects appeared to be mediated by a G-protein-coupled receptor at the membrane surface.
One difference between our results and previous reports is the steroid concentrations required to elicit maximal effects. In hippocampal neurons, micromolar concentrations of corticosteroids are required to maximally reduce Ba2+ currents (ffrench-Mullen and Spence, 1991; ffrench-Mullen et al., 1994; ffrench-Mullen, 1995) . Although some steroids may be synthesized within the brain and reach micromolar concentrations (Corpechot et al., 1983; Lanthier and Patwardham, 1986; Baulieu and Robel, 1990) , there is no evidence that this is the case for estrogen. We found that 17P-estradiol was maximally effective in inhibiting Ca2+ channels at picomolar concentrations, close to those concentrations found in the blood of late proestrus rats (Smith et al., 1975) . Although the effects of 17/3-estradiol were dose-dependent, extremely low concentrations of the hormone also produced reduction of Ba2+ currents. The ability of lower concentrations of 17P-estradiol to modulate currents may be attributable to the lipophilic properties of the steroid and the experimental paradigm. The membrane of a dissociated neuron may act as an "estrogen sink," raising the concentration in the membrane several log units above that in the aqueous phase (Stein, 1986) . How partitioning is regulated in situ is a question of obvious importance for determining the physiological impact of circulating estrogen. However, the dose response also is complicated by the fact that 17P-estradiol appears to reduce Ba2+ currents via G-protein activation. Although it appears 17/3-estradiol reduces Ba2+ currents via a receptor embedded in the cellular membrane, the steroidbinding site need not be on the external face. The binding site may be within the outer membrane layer of the cell. Externally applied 17P-estradiol should enter and diffuse quickly within this external lipid leaflet, only slowly "flipping"
into the interGiP Figure 8 . 17P-Estradiol inhibition of neostriatal Ba*+ currents appeared to occur via G-protein activation.
A, Time course of 17P-estradiol (100 PM) modulation in a neostriatal neuron dialyzed with GTPyS. In the presence of GTPyS, the effect of 17/3-estradiol did not reverse readily with removal of agonist, in contrast to the situation with GTP dialysis. B, Statistical summary of the percent recovery when the neuron was dialyzed with either GTP (200 FM) or GTPyS (400 PM). The effects of estradiol were less likely to reverse in neurons perfused with GTPyS (p < 0.05).
nal lipid layer. The fact that dialyzing neostriatal neurons intracellularly with 17P-estradiol has no apparent influence on the effectiveness of externally applied 17P-estradiol is consistent with this model. Although the magnitude of the modulation by 17@-estradiol was somewhat less when the cell was intracellularly dialyzed with this steroid, this phenomenon likely is caused by our waiting at least 5 min between cell rupture and recording.
As shown in Figure 3 , the effect of 17P-estradiol decreases over time. The ability to reverse rapidly the effects of 17P-estradiol with washing also suggests that the binding site is not energetically remote from the external medium. By analogy, nifedipine, also a lipophilic compound, blocks L-type Ca2+ channels by binding to a channel site accessible from within the membrane, rather than a site approached from the mouth of the pore (Hille, 1992b) . The effects of nifedipine, like those of 17/3-estradiol, can be rapidly reversed with our perfusion system after drug removal (see Fig. 3 ).
An argument for the effect of 17/3-estradiol being mediated by a specific estrogen receptor is that the modulation was both stereospecific and steroid-specific. 17a-Estradiol was considerably less effective than 17P-estradiol. Estrone and 2-methoxyestriol also were less effective than 17/3-estradiol. However, estriol and 4-hydroxyestradiol, two steroids with an additional hydroxyl group, were equally effective. Apparently, there is more than one site on the estrogen molecule important for receptor activation.
Estriol is hydroxylated at carbon 16, whereas 4-hydroxyestradiol is hydroxylated at carbon 4. Neither of these alterations appeared to affect the efficacy of the steroid. Moreover, estrone differs from 17P-estradiol at carbon 17, and 2-methoxyestriol differs from estriol at carbon 2; yet both were less effective than 17@-estradiol in reducing currents. The data suggest that if 17/3-estradiol is binding to a membrane receptor, then it can interact with both sides of the molecule. The binding of steroids to the intracellular estrogen receptor exhibits similar properties (i.e., lack of site specificity) (Anderson et al., 1975; Davies et al., 1975; Martucci and Fishman, 1979; Kirchhoff et al., 1984) . However, it should be noted that binding cannot be equated readily to receptor activation.
At equimolar concentrations, tamoxifen did not antagonize the effects of 17/3-estradiol effectively. Although tamoxifen and its metabolites generally are considered to be antagonists at the intracellular receptor, tamoxifen also can induce estrogenic effects (Jordan, 1984; Jordan and Murphy, 1990) . It has been reported also that tamoxifen has cellular actions independent Figure 9 . The modulation by 17P-&radio1 was neither voltagedependent nor intracellular Ca'~' chelation-dependent. A, Ba2+ currents evoked by a step to 0 mV from a holding potential of -90 mV in the presence and absence of estradiol (1 PM). B, Ba2+ currents evoked by a step to 0 mV when preceded by a 30 msec prepulse to + 100 mV. Note that the estradiol modulation is unaffected by the prepulse. Inset, Box-plot summary of the percent modulation after the depolarizing prepulse (compared with control modulation). Cd *+-insensitive currents were subtracted from all traces. C, Variation in the intracellular concentration of the Ca*' chelator BAPTA did not alter the magnitude of the modulation by 17/3-estradiol, suggesting that the second-messenger pathway by which 17P-estradiol inhibits Ca2+ channels is Ca'+-independent, Shown are the peicent reductions in peak current produced by i7P-estradiol (at least 1 PM) in recordings with 0.1 and 10 IIIM BAPTA dialysates (no added Ca*+). Bars et al., 1985; Su et al., 1985; Issandou et al., 1990 ) and, at high concentrations, competes for neostriatal dopamine receptors (Hiemke and Ghraf, 1984) . These observations are consistent with the partially additive effects of tamoxifen and 17P-estradiol in modulating Bazt currents observed in this study.
Often, it is assumed that activation of intracellular steroid receptors results in long-term changes in gene expression. Nongenomic actions, on the other hand, are believed to be rapid in onset but fleeting in duration. However, this may not necessarily be true. L-Type Ca2+ channels are found primarily in somatic and proximal dendritic membrane (Westenbroek et al., 1990; Hell et al., 1993) . By decreasing L-type currents, 17/3-estradiol may affect the spike generation and patterning of the neuron, but also gene transcription (Murphy et al., 1991; Bading et al., 1993 Of interest, the reduction of Bazt currents by 17P-estradiol was somewhat faster (maximal effects occurred after several seconds) when applied directly to neostriatal neurons than that reported previously when 17P-estradiol was applied to slices (several minutes) (Nabekura et al., 1986; Becker, 1990a) . Moreover, changes that occur when estradiol is administered in vivo take somewhat longer (15 minutes to several hours) (Becker et al., 1987; Levesque and Di Paolo, 1988; Bazzett and Becker, 1994) . The onset of the effects from 17/3-estradiol likely is a reflection of the delivery mechanism used in each experiment.
17P-Estradiol was effective in reducing Bazt currents in nearly all neurons tested. Recorded cells displayed the morphology and surface area typical of medium spiny projection neurons. Projection neurons in the neostriatum, however, are not homogeneous: one group projects to the globus pallidus, whereas the other projects to both the globus pallidus and the substantia nigra (Kawaguchi et al., 1990; Gerfen, 1992) . The neostriatum can be subdivided further with anatomical markers into patch and matrix compartments (Pert et al., 1976; Gerfen et al., 198.5; Bolam et al., 1988; Gerfen, 1989) . Because a vast majority of neurons were affected by 17P-estradiol, it is likely that neurons from each of these anatomical groupings are estrogen-sensitive. Future studies will determine whether the response to 17/3-estradiol differs between these different types of neurons, an important consideration when attempting to understand how 17P-estradiol affects basal ganglia functioning.
Aside from the involvement of a G-protein, the signaling mechanism by which estrogen reduces Ba2+ currents must await further study. L-Type channels can be modulated via several discrete mechanisms in neostriatal neurons. D, dopamine agonists, for example, enhance L-type currents via a protein kinase A cascade involving a pertussis toxin (PTX)-insensitive G-protein and adenylyl cyclase (Surmeier et al., 1995) . On the other hand, muscarinic agonists inhibit L-type currents via a pathway involving a PTX-insensitive G-protein (Howe and Surmeier, 1995) . This pathway appears to depend on the release of inositol triphos-phates (IP,) and the release of intracellular Ca*+. Of interest, estrogen also has been shown to increase IP, synthesis in other cell types (Morley et al., 1992) . However, 17/3-estradiol was effective in reducing Bazt currents through Cazt channels when the intracellular Ca2+ was chelated to low nanomolar levels, suggesting that 17/3-estradiol is acting via a second-messenger system not involved with the release of intracellular Ca2+. It is important to determine the relationship between the reduction by 17/Sestradiol on Cazt currents and other estrogenmediated changes in rat neostriatum.
The role of neostriatal dopamine neurotransmission on locomotor behavior is well documented. Because Ca2+ is crucial for neurotransmitter release and modifies intracellular changes induced by receptor activation, the question remains whether the reduction of Cazt currents by 17/3-estradiol is responsible for the effects observed previously on neostriatal dopaminergic systems and behaviors. Future studies will determine whether these phenomena are causally related.
In summary, 17/3-estradiol reduces neostriatal Ba2+ currents through Cazf channels via activation of a G-protein-signaling pathway. The effect is greater in female neostriatal neurons than in cells taken from male rats, and the magnitude of the reduction is steroid-specific. These effects occur at physiological concentrations and may play an important role in alterations in motor performance during different stages of the estrus cycle. 
